This website is for the U.S, for the other countries please refer to this link.

SCIENTIFIC NEWS
Diabetes
Impeto Medical

SUDOSCAN utility to detect foot sudomotor dysfunction in type 1 diabetes without clinical evidence of peripheral neuropathy

SUDOSCAN UTILITY TO DETECT FOOT SUDOMOTOR DYSFUNCTION IN TYPE 1 DIABETES WITHOUT CLINICAL EVIDENCE OF PERIPHERAL NEUROPATHY Danyelle Lorrane Carneiro Veloso, Raira Castilho Gomes Nascimento, Eliziane Brandao Leite, Luisiane de Avila Santana, Angelica Amorim Amato. Article title: Predictors of sudomotor dysfunction in patients with type 1 diabetes without clinical evidence of peripheral neuropathy. Diabetes Research and

Read More »
November 20, 2020 No Comments
Diabetes
Impeto Medical

Clinical impact of dpp-4 inhibitor on autonomic neuropathy followed up by SUDOSCAN

CLINICAL IMPACT OF DPP-4 INHIBITOR ON AUTONOMIC NEUROPATHY FOLLOWED UP BY SUDOSCAN​ A. Syngle, S. Chahal, K. Vohra. Article title: Efficacy and tolerability of DPP4 inhibitor, teneligliptin, on autonomic and peripheral neuropathy in type 2 diabetes: an open label, pilot study. Neurological Sciences. 2020 Aug 15. A new publication by Syngle et al. in Neurological

Read More »
August 25, 2020 No Comments
Neurological diseases
Impeto Medical

SUDOSCAN combined to other diagnosis tests to confirm small fiber neuropathy

SUDOSCAN COMBINED TO OTHER DIAGNOSIS TESTS TO CONFIRM SMALL FIBER NEUROPATHY   V. Fabry, A. Gerdelat, B. Acket, P. Cintas, V. Rousseau, E. Uro-Coste, S. M. Evrard and A. Pavy-Le Traon. Article title: “Which Method for Diagnosing Small Fiber Neuropathy?” Front. Neurol., 05 May 2020. In a recent study conducted at Toulouse University Hospital, France,

Read More »
July 30, 2020 No Comments
Events
Impeto Medical

Successful web conference 2020 on SUDOSCAN utility in diabetes

SUCCESSFUL WEB CONFERENCE ON SUDOSCAN UTILITY IN DIABETES On July the 10th Impeto Medical has organized a web conference for diabetologists: Management of diabetic foot risk – a UK experience in quick screening and multifactorial interventions. During this web conference we had the pleasure to get an enriching feedback from Dr Dinesh SELVARAJAH (Senior Lecturer

Read More »
July 30, 2020 No Comments
Diabetes
Impeto Medical

The utility of SUDOSCAN to diagnose diabetic cardiovascular autonomic neuropathy and diabetic polyneuropathy

THE UTILITY OF SUDOSCAN TO DIAGNOSE DIABETIC CARDIOVASCULAR AUTONOMIC NEUROPATHY AND DIABETIC POLYNEUROPATHY C. D’amato, C. Greco, G. Lombardo, V. Frattina, M. Campo, C.M.A. Cefalo, V. Izzo, D. Lauro, V. Spallone. Article title: “The diagnostic usefulness of the combined COMPASS 31 questionnaire and electrochemical skin conductance for diabetic cardiovascular autonomic neuropathy and diabetic polyneuropathy” J

Read More »
March 11, 2020 No Comments
Diabetes
Impeto Medical

The benefits of SUDOSCAN in early diagnosis of diabetic peripheral neuropathy reviewed in The Lancet

THE BENEFITS OF SUDOSCAN IN EARLY DIAGNOSIS OF DIABETIC PERIPHERAL NEUROPATHY REVIEWED IN THE LANCET Selvarajah D, Kar D, Khunti K, Davies MJ, Scott AR, Walker J, Tesfaye S. Article title: “Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention”. The Lancet Diabetes Endocrinol 2019. Volume 7, Issue 12, p938-948, December

Read More »
January 8, 2020 No Comments

More information about SUDOSCAN ?

CONTACT US
Feel free to contact us with your question

Promotional Communication. The medical devices SUDOSCAN is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12

Scroll to Top